Development, Education, Research
Our lab studies a class of compounds that we call psychoplastogens, or small molecules capable of promoting neural plasticity. Such compounds have enormous potential for treating a wide variety of neuropsychiatric diseases including depression, anxiety disorders, and addiction. We use a combination of synthetic chemistry, molecular neurobiology, and behavioral neuropharmacology to 1) understand the fundamental mechanisms underlying the effects of psychoplastogens on the nervous system, and 2) develop next generation neurotherapeutics.
Davis, California, USA
David Olson (Founder)